http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102186872-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4409 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
filingDate | 2009-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102186872-B |
titleOfInvention | Resist extensive Resistance Mycobacterium Tuberculosis medicine, anti-Drug-fast case tubercule bacillus medicine and and use antitubercular agent |
abstract | There is provided to the effective anti-XDR-TB medicine of extensive Resistance Mycobacterium Tuberculosis with to the effective anti-Drug-fast case tubercule bacillus MDR-TB medicine of Drug-fast case tubercule bacillus and to effective for the tubercule bacillus of existing antitubercular agent sensitivity and use antitubercular agent.The present invention for comprise the compound represented by following structural formula (1) anti-XDR-TB medicine, comprise the compound represented by following structural formula (1) anti-Drug-fast case tubercule bacillus medicine and and with containing the medicine of compound represented by following structural formula (1) and at least one antitubercular agent selected the antitubercular agent of vazadrine from the antitubercular agent containing Rifampin and containing and use antitubercular agent.n structural formula (1) (CPZEN-45). |
priorityDate | 2008-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.